Colorectal Cancer Detection by Colonoscopy in Population Aged 50–70 Years with Positive Fecal Occult Blood Test: A Retrospective Cohort Study, Rasi Salai Hospital, Sisaket province
Main Article Content
Abstract
Colorectal cancer mortality is increasing in Thailand. Screening with the fecal immunochemical test (FIT) followed by colonoscopy for FIT-positive individuals is an effective strategy to reduce mortality; however, evidence on colonoscopy quality indicators in community hospitals remains limited. The objective was to estimate the adenoma detection rate (ADR) among FIT-positive adults undergoing colonoscopy and factors associated with polyp detection. The method conducted a retrospective cohort study of adults aged 50–70 years with positive FIT results who underwent colonoscopy at Rasisalai Hospital during 2023–2025. Data were extracted from medical records and colonoscopy reports, including demographics, body mass index, health behaviors, colonoscopy findings, histopathology, cancer stage, and bowel preparation quality assessed by the Aronchick Scale. Descriptive statistics and inferential analyses (Chi-square or Fisher’s exact test, t-test, and multivariable logistic regression) were performed. The results occurred among 365 FIT-positive patients; 51.8% were female, and the mean age was 60.8±6.4 years. Polyps were detected in 130 patients (35.6%), and adenomatous polyps were identified in 103 patients, yielding an ADR of 28.2%. Colorectal cancer was diagnosed in 4.4% of patients; more than half were early stage, and the most common tumor site was the sigmoid colon (38.8%). Adequate bowel preparation was achieved in 96.2% of procedures, the cecal intubation rate was 96.4%, and one perforation occurred (0.3%). Adequate preparation rates were not different between polyethylene glycol and sodium phosphate (97.3% vs. 95.4%; p = 0.36). In multivariable analysis, increasing age at adjusted OR = 1.09 (95% CI 1.05–1.14; p < 0.001) and alcohol consumption at adjusted OR = 1.69 (95% CI 1.00–2.86; p = 0.049) were associated with polyp detection, whereas BMI and smoking were not. The conclusions found that in FIT-positive adults undergoing colonoscopy in a community hospital, ADR was 28.2% and met the American Society for Gastrointestinal Endoscopy (ASGE)-recommended benchmark, with high cecal intubation and adequate bowel preparation rates and a very low complication rate. Increasing age and alcohol consumption were significant risk factors for polyp detection.
Article Details
เนื้อหาและข้อมูล (เขียนข้อกำหนด)
References
ประเวทย์ แสงวันลอย. (2564). สถานการณ์โรคมะเร็งในประเทศไทย พ.ศ. 2561–2563. กรุงเทพฯ: กระทรวง
สาธารณสุข.
Bailey, J. A. (2024). Optimisation of faecal immunochemical test (FIT) for symptomatic colorectal
cancer diagnosis (Doctoral dissertation, University of Nottingham).
Ben, Q., Wang, L., Liu, J., Qian, A., Wang, Q., & Yuan, Y. (2015). Alcohol drinking and the risk of
colorectal adenoma: A dose–response meta-analysis. European Journal of Cancer
Prevention, 24(4), 286–295. https://doi.org/10.1097/CEJ.0000000000000077
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., & Jemal, A. (2024). Global cancer statistics
: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185
countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263.
https://doi.org/10.3322/caac.21834
Cai, S., Li, Y., Ding, Y., Chen, K., & Jin, M. (2014). Alcohol drinking and the risk of colorectal cancer
death: A meta-analysis. European Journal of Cancer Prevention, 23(6), 532–539.
https://doi.org/10.1097/CEJ.0000000000000076
Chinaroonchai, T. (2023). Adenoma detection rate and quality indicators for colonoscopy in Phang
Nga Hospital. Reg 11 Med J, 37(4), 58–70.
Corley, D. A., Jensen, C. D., Marks, A. R., Zhao, W. K., Lee, J. K., Doubeni, C. A., Zauber, A. G., de Boer,
J., Fireman, B. H., Schottinger, J. E., Quinn, V. P., Ghai, N. R., Levin, T. R., & Quesenberry, C. P.
(2014). Adenoma detection rate and risk of colorectal cancer and death. The New England
Journal of Medicine, 370(14), 1298–1306. https://doi.org/10.1056/NEJMoa1309086
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019). Colorectal cancer. The
Lancet, 394(10207), 1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0
Diamond, S. J., Enestvedt, B. K., Jiang, Z., Holub, J. L., Gupta, M., Lieberman, D. A., & Eisen, G. M.
(2011). Adenoma detection rate increases with each decade of life after 50 years of age.
Gastrointestinal Endoscopy, 74(1), 135–140. https://doi.org/10.1016/j.gie.2011.03.1178
Fedirko, V., Tramacere, I., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Negri, E., Straif, K., Romieu, I., La
Vecchia, C., Boffetta, P., & Jenab, M. (2011). Alcohol drinking and colorectal cancer risk: An
overall and dose–response meta-analysis of published studies. Annals of Oncology, 22(9),
–1972. https://doi.org/10.1093/annonc/mdq653
Hassan, C., East, J., Radaelli, F., Spada, C., Benamouzig, R., Bisschops, R., & Dumonceau, J.-M. (2019).
Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE)
guideline—Update 2019. Endoscopy, 51(8), 775–794. https://doi.org/10.1055/a-0959-0505
Hassan, C., Wysocki, P. T., Fuccio, L., Seufferlein, T., Dinis-Ribeiro, M., Brandão, C., Regula, J., Frazzoni,
L., Pellise, M., Alfieri, S., Dekker, E., Jover, R., Rosati, G., Senore, C., Spada, C., Gralnek, I.,
Dumonceau, J.-M., van Hooft, J. E., van Cutsem, E., & Ponchon, T. (2019). Endoscopic
surveillance after surgical or endoscopic resection for colorectal cancer: European Society
of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO)
guideline. Endoscopy, 51(3), 266–277. https://doi.org/10.1055/a-0831-2522
International Agency for Research on Cancer. (2026, February 11). Agents classified by the IARC
Monographs, Volumes 1–140. IARC Monographs on the Identification of Carcinogenic
Hazards to Humans. https://monographs.iarc.who.int/agents-classified-by-the-iarc/
Juluri, R., Eckert, G., & Imperiale, T. F. (2010). Meta-analysis: Randomized controlled trials of 4-L
polyethylene glycol and sodium phosphate solution as bowel preparation for colonoscopy.
Alimentary Pharmacology & Therapeutics, 32(2), 171–181. https://doi.org/10.1111/j.1365-
2010.04326.x
Juntong, J., & Thammawijaya, P. (2024). Prevalence of colorectal polyp and cancer from
colonoscopy screening in adults aged 45 and above, 2022–2024. Journal of the Association
of General Surgeons of Thailand, 9(3), 75–87.
Kaminski, M. F., Regula, J., Kraszewska, E., Polkowski, M., Wojciechowska, U., Didkowska, J., Zwierko,
M., Rupinski, M., Nowacki, M. P., & Butruk, E. (2010). Quality indicators for colonoscopy and
the risk of interval cancer. The New England Journal of Medicine, 362(19), 1795–1803.
https://doi.org/10.1056/NEJMoa0907667
Kaminski, M. F., Thomas-Gibson, S., Bugajski, M., Bretthauer, M., Rees, C. J., Dekker, E., & Rutter, M. D.
(2017). Performance measures for lower gastrointestinal endoscopy: A European Society of
Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy, 49(4), 378–
https://doi.org/10.1055/s-0043-103411
Mongkhonsupphawan, A., Sethalao, N., & Riansuwan, W. (2022). Long-term oncologic outcomes after
curative surgery in stage I–III Thai colorectal cancer patients. Siriraj Medical Journal, 74(11),
–746.
Paragomi, P., Zhang, Z., Abe, S. K., Islam, M. R., Rahman, M. S., Saito, E., … Luu, H. N. (2024). Body
mass index and risk of colorectal cancer incidence and mortality in Asia. JAMA Network
Open, 7(8), e2429494. https://doi.org/10.1001/jamanetworkopen.2024.29494
Robinson, M. H., Hardcastle, J. D., Moss, S. M., Amar, S. S., Chamberlain, J. O., Armitage, N. C.,
Scholefield, J. H., & Mangham, C. M. (1999). The risks of screening: Data from the
Nottingham randomised controlled trial of faecal occult blood screening for colorectal
cancer. Gut, 45(4), 588–592. https://doi.org/10.1136/gut.45.4.588
Rex, D. K., Boland, C. R., Dominitz, J. A., Giardiello, F. M., Johnson, D. A., Kaltenbach, T., Levin, T. R.,
Lieberman, D., & Robertson, D. J. (2017). Colorectal cancer screening: Recommendations for
physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
Gastrointestinal Endoscopy, 86(1), 18–33. https://doi.org/10.1016/j.gie.2017.04.003
Ruiz-Rebollo, M. L., Alcaide-Suárez, N., Burgueño-Gómez, B., Antolin-Melero, B., Muñoz-Moreno, F.,
Alonso-Martín, C., & Santos-Fernández, J. (2019). Adenoma detection rate and cecal
intubation rate: Quality indicators for colonoscopy. Gastroenterología y Hepatología, 42(4),
–255.
Shaukat, A., Mongin, S. J., Geisser, M. S., Lederle, F. A., Bond, J. H., Mandel, J. S., & Church, T. R.
(2013). Long-term mortality after screening for colorectal cancer. The New England Journal
of Medicine, 369(12), 1106–1114. https://doi.org/10.1056/NEJMoa1300720
Wang, J., Huang, L., Gao, Y., Wang, Y., Chen, S., Huang, J., Zheng, W., Bao, P., Gong, Y., Zhang, Y.,
Wang, M., & Wong, M. C. S. (2020). Physically active individuals have a 23% lower risk of any
colorectal neoplasia and a 27% lower risk of advanced colorectal neoplasia than their non-
active counterparts: Systematic review and meta-analysis of observational studies. British
Journal of Sports Medicine, 54(10), 582–591. https://doi.org/10.1136/bjsports-2018-100350
Wu, S., Zhang, Y., Lin, Z., & Wei, M. (2025). Global burden of colorectal cancer in 2022 and
projections to 2050: Incidence and mortality estimates from GLOBOCAN. BMC Cancer, 25(1),